Frances Tanner
Nurse Practitioner · Jacksonville, FLNPI 1841777588
Payments from drug & device makers
Across 439 payments — averaging $25.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$1K
- Pfizer$1K
- Actelion Pharmaceuticals US, Inc.$1K
- Amgen$923
- Novartis$858
- Bayer$773
- plus $5K from 33 others
What the payments were for
- Food & beverage$10,60896%
- Education$4424%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Therapeutics Corporation | 28 | $1,176 |
| Pfizer | 40 | $1,103 |
| Actelion Pharmaceuticals US, Inc. | 36 | $1,076 |
| Amgen | 42 | $923 |
| Novartis | 49 | $858 |
| Bayer | 36 | $773 |
| Merck | 33 | $749 |
| Boehringer Ingelheim | 28 | $716 |
| Johnson & Johnson(2 entities) | 17 | $534 |
| Esperion Therapeutics, Inc. | 25 | $498 |
| Boston Scientific | 10 | $436 |
| AstraZeneca | 20 | $344 |
| Novo Nordisk | 18 | $343 |
| Biotronik Inc. | 4 | $204 |
| Edwards Lifesciences | 1 | $131 |
| Penumbra, Inc. | 1 | $121 |
| Abbott | 1 | $90 |
| Baxter Healthcare | 5 | $89 |
| Scpharmaceuticals Inc. | 4 | $87 |
| Amarin Pharma, Inc. | 5 | $85 |
| Philips North America LLC | 3 | $84 |
| Alnylam Pharmaceuticals Inc. | 4 | $78 |
| E.r. Squibb & Sons, L.L.C. | 4 | $68 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $66 |
| Daiichi Sankyo Inc. | 3 | $63 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $59 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $46 |
| Liquidia Technologies, Inc. | 1 | $32 |
| Irhythm Technologies, Inc. | 2 | $32 |
| Distalmotion US | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Bristol Myers Squibb | 1 | $21 |
| Shockwave Medical, Inc | 1 | $19 |
| Lexicon Pharmaceuticals, Inc. | 1 | $18 |
| Abiomed | 1 | $17 |
| Sanofi | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| GSK | 1 | $16 |
| Kestra Medical Technology Services, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$273
- Repatha$257
- WATCHMAN Access System$133
- SAPIEN 3 Ultra RESILIA$131
- TYVASO$122
- Penumbra System$121
- VYNDAQEL$120
How this compares
$11,050 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tyvaso DpiTreprostinil | 33 | $783,586 |
| AdempasRiociguat | 42 | $578,938 |
| OpsumitMacitentan | 30 | $380,741 |
| UptraviSelexipag | 11 | $258,628 |
| EliquisApixaban | 124 | $140,835 |
| XareltoRivaroxaban | 133 | $131,039 |
| JardianceEmpagliflozin | 84 | $108,771 |
| Repatha SureclickEvolocumab | 92 | $87,728 |
| EntrestoSacubitril/Valsartan | 56 | $69,373 |
| FarxigaDapagliflozin Propanediol | 27 | $41,459 |
| OzempicSemaglutide | 16 | $23,535 |
| Ranolazine ErRanolazine | 67 | $8,186 |
| Rosuvastatin Calcium | 473 | $6,095 |
| BrilintaTicagrelor | 12 | $5,327 |
| Ezetimibe | 261 | $4,485 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Actelion Pharmaceuticals US, Inc.Opsumit, Uptravi | $1,076 | $639,36941 claims |
| BayerAdempas | $773 | $578,93842 claims |
| PfizerEliquis | $1,103 | $140,835124 claims |
| Johnson & JohnsonXarelto | $534 | $131,039133 claims |
| Boehringer IngelheimJardiance | $716 | $108,77184 claims |
| NovartisEntresto | $858 | $69,37356 claims |
| AstraZenecaFarxiga, Brilinta | $344 | $46,78539 claims |
| Novo NordiskOzempic | $343 | $23,53516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Jacksonville
- Mary FarrJacksonville$66K
- Stacey KellyJacksonville$22K
- Jean Sheridan-YoungJacksonville$22K
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.